ROBERTS EIRY bought NBIX
December 17, 2024 · Form 4 insider transaction
ROBERTS EIRY bought 27,770 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,770
Price
$0.00
Total value
N/A
InsiderROBERTS EIRY
RoleDirector
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateDecember 17, 2024
Filing dateDecember 19, 2024
Shares owned after27,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an option of which 1/4 of the shares underlying the option becomes vested and exercisable on February 13, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter beginning on March 13, 2025, such that the option shall fully vest on February 13, 2028.